MDBU, also known as 3,4-methylenedioxy-N-butylamphetamine or as N-butyl-MDA, is a lesser-known drug.[1][2] It is the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA).[1][2]
| Clinical data | |
|---|---|
| Other names | MDBU; 3,4-Methylenedioxy-N-butylamphetamine; N-Butyl-MDA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO2 |
| Molar mass | 235.327 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
editChemistry
editSynthesis
editThe chemical synthesis of MDBU has been described.[1]
See also
editReferences
edit- 1 2 3 4 5 6 7 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. MDBU entry
- 1 2 3 Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.